West Pharmaceutical Services, Inc. (WST)
393.67
-3.02
(-0.76%)
USD |
NYSE |
Nov 20, 10:35
West Pharmaceutical Services Free Cash Flow : 453.40M for Sept. 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2026 | 453.40M |
| June 30, 2026 | 436.90M |
| March 31, 2026 | 458.00M |
| December 31, 2025 | 468.90M |
| September 30, 2025 | 379.10M |
| June 30, 2025 | 344.00M |
| March 31, 2025 | 306.90M |
| December 31, 2024 | 276.40M |
| September 30, 2024 | 321.60M |
| June 30, 2024 | 357.10M |
| March 31, 2024 | 386.10M |
| December 31, 2023 | 414.50M |
| September 30, 2023 | 420.00M |
| June 30, 2023 | 396.80M |
| March 31, 2023 | 410.00M |
| December 31, 2022 | 439.40M |
| September 30, 2022 | 387.80M |
| June 30, 2022 | 401.50M |
| March 31, 2022 | 382.00M |
| December 31, 2021 | 330.60M |
| September 30, 2021 | 341.10M |
| June 30, 2021 | 287.40M |
| March 31, 2021 | 307.10M |
| December 31, 2020 | 298.10M |
| September 30, 2020 | 272.10M |
| Date | Value |
|---|---|
| June 30, 2020 | 277.40M |
| March 31, 2020 | 247.00M |
| December 31, 2019 | 240.80M |
| September 30, 2019 | 215.20M |
| June 30, 2019 | 200.70M |
| March 31, 2019 | 185.70M |
| December 31, 2018 | 183.90M |
| September 30, 2018 | 192.70M |
| June 30, 2018 | 172.30M |
| March 31, 2018 | 166.30M |
| December 31, 2017 | 132.50M |
| September 30, 2017 | 104.80M |
| June 30, 2017 | 83.00M |
| March 31, 2017 | 68.40M |
| December 31, 2016 | 49.20M |
| September 30, 2016 | 48.10M |
| June 30, 2016 | 67.50M |
| March 31, 2016 | 77.10M |
| December 31, 2015 | 80.80M |
| September 30, 2015 | 76.50M |
| June 30, 2015 | 72.70M |
| March 31, 2015 | 61.60M |
| December 31, 2014 | 71.00M |
| September 30, 2014 | 82.10M |
| June 30, 2014 | 70.80M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Globus Medical, Inc. | 766.47M |
| Glaukos Corp. | 19.41M |
| The Cooper Cos., Inc. | 678.00M |
| Intuitive Surgical, Inc. | 3.598B |
| Becton, Dickinson & Co. | 2.693B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 189.50M |
| Cash from Investing (Quarterly) | 78.90M |
| Cash from Financing (Quarterly) | -241.80M |
| Free Cash Flow Per Share (Quarterly) | 2.124 |
| Free Cash Flow to Equity (Quarterly) | 153.00M |
| Free Cash Flow to Firm (Quarterly) | 153.30M |
| Free Cash Flow Yield | 1.65% |